MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Digital Rehab Tech Startup Raises $11M

Image courtesy of Imperial College London GripAble digital therapeutic tech.png
In just over five years GripAble has rocketed from being a laboratory design concept to a therapeutic used in hundreds of centers globally.

A digital rehab tech startup that spun out of Imperial College London has $11 million of new funding to expand the reach of its technology.

GripAble, formed by researchers at Imperial College London and clinicians at Imperial College Healthcare NHS Trust, develops a digital assessment and training platform designed to support people undergoing rehabilitation for both neurological and musculoskeletal conditions. With a focus on hand and arm function, rehabilitation programs are delivered through interactive mobile technologies that have been designed to motivate, track progress, and provide real-time biofeedback.

GripAble was an early investment in the Parkwalk-managed Imperial College Innovation Fund (ICIF) and is the third ICIF company to go on to raise a substantial subsequent round.

Clinical trials have shown that GripAble’s platform can increase the amount of arm exercises stroke patients do without professional supervision.

IP Group led the new funding with equal investment from Parkwalk Advisors.

The company was founded to help patients with arm weakness achieve the number of repetitive movements needed for rehabilitation. The device has been used by more than 8,000 people.

"In just over five yars, GripAble has rocketed from being a laboratory design concept to an actual therapeutic used in hundreds of centers globally," said Dr. Paul Bentley, clinical director of the Imperial College Network of Excellence in Rehabilitation Technology. "This is a paragon of translational research, and made possible by inter-disciplinary collaborations between engineering and medicine, highly motivated junior researchers (who now run the company); and thanks to seed funding from the Sir Leon Bagrit Memorial Trust and the Imperial Enterprise Division. This new funding will allow GripAble to expand its reach so that more people will be able to access and benefit this technology.”

Read the full story here.

Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish